Company Profile
Updated: 09-SEP-09Isoray Medical Inc.
Private Company, Headquarters Location
350 Hills St., Ste. 106, Richland, WA 99354, United States
(509)375-1202,
Primary SIC: Surgical And Medical Instruments, Primary NAICS: Surgical and Medical Instrument Manufacturing
Description: Manufacturing: Manufactures medical instruments
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
IsoRay Announces Iodine Distribution Agreement with GE Subsidiary, Oncura.
Business Wire; 12/3/2009; 1300 words; ...Inter V Medical, thus providing additional revenue and margins to IsoRay." About IsoRay IsoRay, Inc., through its subsidiary, IsoRay Medical, Inc., is the sole producer of the Cesium-131 brachytherapy seed. The Cesium-131 seed offers...
IsoRay, Inc. Reports First Quarter Results.(Financial report)
Biotech Week; 12/2/2009; 1020 words; IsoRay Inc. (AMEX:ISR) a medical isotope company focusing on the treatment of prostate...other tumor locations." About IsoRay IsoRay, Inc., through its subsidiary, IsoRay Medical, Inc., is the sole producer of the Cesium-131 brachytherapy...
IsoRay Announces Distribution Agreement in Canada.
Cancer Weekly; 12/1/2009; 1010 words; ...approved by Health Canada (see also IsoRay, Inc.). Inter V Medical has been bringing new medical technologies...IsoRay products." About IsoRay IsoRay, Inc., through its subsidiary, IsoRay Medical, Inc., is the sole producer of the Cesium...
IsoRay Inks Canada Distribution Deal.
Investrend; 11/19/2009; 593 words; ...net/2009/11/19/isoray-inks-canada-distribution...FinancialWire) -- IsoRay, Inc. (AMEX: ISR) said...agreement with Inter V Medical of Montreal, Quebec...Canada. Washington-based IsoRay is the sole producer of...
IsoRay Releases 1Q Fiscal 2010 Results.(Financial report)
Health & Beauty Close-Up; 11/19/2009; 750 words; IsoRay Inc., a medical isotope company focusing on the treatment...quarter of fiscal 2009. However, 50 medical centers ordered the Company's Proxcelan...During the first quarter of FY2010, IsoRay commenced shipping seeds for use in...
Recent News Articles
- IsoRay Medical, Inc., Set to Transfer Production of Proxcelan(TM) (Cesium-131) Brachytherapy Seeds to New Expanded Facilities in Richland.
Business Wire - August 30, 2007 - IsoRay Medical, Inc. Introduces Branding of Cesium-131 as Proxcelan(TM) for Use in Prostate Cancer Brachytherapy.
Business Wire - July 20, 2007 - IsoRay Medical, Inc. and the Applied Process Engineering Laboratory Sign Lease for New Cesium-131 Production Facility in Richland.
Business Wire - May 09, 2007 - Cesium-131 From IsoRay Medical (TM), Inc. Established as a Front Line Treatment for Early Stage Prostate Cancer Treatment in a Recent Clinical Trial.
Business Wire - April 30, 2007
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning